About Broken String Biosciences
Broken String Biosciences is a company based in Cambridge (United Kingdom) founded in 2020 by Felix Dobbs, Simon Reed, and Patrick van Eijk. Broken String Biosciences has raised $15 million across 3 funding rounds from investors including Tencent, Illumina and Illumina Ventures. The company has 4 employees. Broken String Biosciences offers products and services including INDUCE-seq® and Catalyst Program. Broken String Biosciences operates in a competitive market with competitors including DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
- Headquarter Cambridge, United Kingdom
- Employees 4
- Founders Felix Dobbs, Simon Reed, Patrick van Eijk
- SectorsHealthcare
- Website brokenstringbio.com
- Social LinkedIn X
- Legal Name Broken String Biosciences Limited
- Date of Incorporation 23 Jan, 2020
- Jurisdiction CAMBRIDGE, ENGLAND
- Total Equity Funding$15M (USD)
in 3 rounds
- Latest Funding Round$15M (USD), Series A
Sep 2023
- InvestorsTencent
& 5 more
- Employee Count4
Products & Services of Broken String Biosciences
Broken String Biosciences offers a comprehensive portfolio of products and services, including INDUCE-seq® and Catalyst Program.
Detects genome breaks for safer gene editing therapies.
Provides early access to tools for gene therapy developers.
Funding Insights of Broken String Biosciences
Broken String Biosciences has successfully raised a total of $15M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15M
- Total Rounds 3
- Last Round Series A — $15M
- Investors Count 6
All 3 funding rounds of Broken String Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2023 | $15M | Series A | – | Illumina Ventures, Merieux Equity Partners | |
| Jan 2022 | – | Seed | – | Dieter von Holtzbrinck Ventures | – |
| Feb 2021 | – | Seed | – | Illumina | – |
6 investors in total: 6 institutional.
Investors in Broken String Biosciences
Broken String Biosciences has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Illumina and Illumina Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health tech startups are invested in by Illumina Ventures. | – | illuminaventures.com | Foster City, United States | |
Pivate equity firm that focuses on investing in healthcare and nutrition companies | – | merieux-partners.com | Lyon, France | |
Venture capital is provided to healthcare and life sciences innovators. | – | heranpartners.com | Antwerp, Belgium | |
Early-stage venture capital investments are made in European startups. | – | dvhventures.de | Köln, Germany | |
Value-added internet, mobile, and telecom services are provided in China. | 1998 | tencent.com | Shenzhen, China | |
Developer of technologies for analysis of genetic variation and function | 1993 | illumina.com | San Diego, United States |
Investor details for Broken String Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Broken String Biosciences
5 people are tracked at Broken String Biosciences (4 in leadership, 1 in team); the tracked headcount is 4.
| Name | Role | Group |
|---|---|---|
Felix Dobbs | Co-Founder & CEO | Leadership |
Simon Reed | Co-Founder & CSO | Leadership |
Patrick van Eijk | Co-Founder & CTO | Leadership |
Kimberly Lapointe | Marketing Director | Leadership |
Kully O'Keeffe | Office Manager & Executive Assistant | Team |
Complete people profiles for Broken String Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Broken String Biosciences
3 dated milestones of Broken String Biosciences across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Broken String Biosciences is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $15.0M.
Competitors of Broken String Biosciences
Broken String Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Genomics, Depixus, Seven Bridges Genomics and Ingenuity Systems, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dnanexus.com | 2009 | Mountain View, United States | $472.55M | 143 | Cloud-based genome informatics and data management are provided. | |
| genomics.com | 2014 | Oxford, United Kingdom | $115.54M | – | Genomic risk assessment and prevention platform is provided. | |
| depixus.com | 2012 | Paris, France | $34.52M | – | Single-molecule genetic and epigenetic sequencing solutions are provided. | |
| sevenbridges.com | 2009 | Cambridge, United States | $113M | 112 | Cloud-based platform to analyze, store, and act on genomic data. | |
| ingenuity.com | 1998 | Redwood, United States | $20.4M | 30 | Genomic data is analyzed and interpreted via web-based applications. | |
| eaglegenomics.com | 2008 | Cambridge, United Kingdom | $38.73M | – | Developer of cloud-based software solutions for genomic analysis | |
| bcplatforms.com | 1997 | Zurich, Switzerland | $47.15M | 8 | Platforms for genomic data analysis and management are provided. | |
| deepgenomics.com | 2015 | Toronto, Canada | $237.96M | – | Machine learning is utilized for precision medicine and genetic diagnostics. | |
| twinstrandbio.com | 2015 | Seattle, United States | $84.02M | 70 | DNA sequencing technology is developed to detect genomic mutations. |
Detailed competitors of Broken String Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Broken String Biosciences
The website of Broken String Biosciences (brokenstringbio.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 119.2% vs previous month
Latest news on Broken String Biosciences
Complete news archive for Broken String Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Broken String Biosciences
10 companies that operate in the same segment as Broken String Biosciences (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Broken String Biosciences
Broken String Biosciences was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Broken String Biosciences is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Felix Dobbs is the current CEO of Broken String Biosciences. They have also founded this company.
Broken String Biosciences is a funded company, having raised a total of $15M across 3 funding rounds to date.
Broken String Biosciences has 4 employees.
Broken String Biosciences was founded in 2020 in Cambridge, United Kingdom, within the biotechnology sector. Biopharmaceutical products and cell therapies are developed using genome sequencing data. Sequencing tools are provided to support medicine creation, including cell and gene therapies for cancer, immunological health, and other diseases. INDUCE-seq technology is utilized to measure DNA breaks across the genome and to evaluate DSB repair mechanisms, enabling therapeutic genome editing applications.
Broken String Biosciences's top competitors include DNAnexus, Eagle Genomics and Depixus.
Broken String Biosciences offers INDUCE-seq® and Catalyst Program.
Broken String Biosciences has 6 investors. Key investors include Tencent, Illumina, Illumina Ventures, Merieux Equity Partners, and Heran Partners.
Broken String Biosciences operates through Broken String Biosciences Limited.